TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.25, sa.6, ss.685-689, 2014 (SCI-Expanded, Scopus, TRDizin)
Background/Aims: In this study, a tenofovir disoproxil fumarate (TDF) + hepatitis B immunoglobulin (HBIG) regimen was compared with lamivudine (LAM) + HBIG to determine the efficacy and safety of TDF in the prevention of hepatitis B virus (HBV) recurrence following liver transplantation (LT).